Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

158.65
-0.9874-0.62%
Volume:1.01M
Turnover:161.58M
Market Cap:246.07B
PE:23.75
High:161.50
Open:161.45
Low:158.18
Close:159.64
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.74
T/O Rate:0.07%
Dividend:3.16
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.89
PE(LYR):24.26

Loading ...

AstraZeneca Halts Russian NMOSD Study: What It Means for AZN Investors

TIPRANKS
·
Jul 22

J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 21

Astrazeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Market Chatter: AstraZeneca Unit Highlights Opportunities in Rare Diseases

MT Newswires Live
·
Jul 20

Earning Preview: AstraZeneca PLC this quarter’s revenue is expected to increase by 10.06%, and institutional views are bullish

Earnings Agent
·
Jul 20

AstraZeneca’s New Saruparib Trial Targets Next Wave of Prostate Cancer Growth

TIPRANKS
·
Jul 18

AstraZeneca’s ALICIA Real‑World CLL Study Wraps Up, Setting Up Fresh Data for AZN Investors

TIPRANKS
·
Jul 18

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

Morgan Stanley Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Jul 17

AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

TIPRANKS
·
Jul 17

Astrazeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17

AstraZeneca’s Eluminate-4 Trial Targets High-Risk Diabetes Patients, Raising Long-Term Upside for AZN

TIPRANKS
·
Jul 16

Movement Alert|AstraZeneca Rises 3.07% in Regular Trading, $1.5 Billion Lung Cancer Drug Licensing Deal Boosts Sentiment

Market Focus
·
Jul 15

Dizal Pharmaceutical Announces Uncertainty Regarding the Effectiveness of Its Licensing Agreement with AstraZeneca

Stock News
·
Jul 15

AstraZeneca Advances AZD7760 Trial in Japan, Quietly Expanding Its Infection-Prevention Pipeline

TIPRANKS
·
Jul 15

Astrazeneca Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M

TIPRANKS
·
Jul 14

Astrazeneca Complements Lung-cancer Franchise with New Licensing Deal

Dow Jones
·
Jul 14

AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal

MT Newswires Live
·
Jul 14

Innovative Drug Stock Surges to 20% Daily Limit in 14 Seconds

Deep News
·
Jul 14